N23 (Neggram 1 GM)
Generic Name: nalidixic acid
Pill with imprint N23 is Yellow, Elliptical / Oval and has been identified as Neggram 1 GM. It is supplied by Sanofi-Synthelabo Inc.
NegGram is used in the treatment of bladder infection; prevention of bladder infection and belongs to the drug classes quinolones, urinary anti-infectives. Risk cannot be ruled out during pregnancy. NegGram 1 GM is not a controlled substance under the Controlled Substances Act (CSA).
Images for N23
Neggram
- Generic Name:
- nalidixic acid
- Imprint:
- N23
- Strength:
- 1 GM
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Quinolones
Urinary anti-infectives - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sanofi-Synthelabo Inc
- National Drug Code (NDC):
- 00024-1323
More about NegGram (nalidixic acid)
- NegGram Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews
- Drug class: quinolones
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
